• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
  • Issues
    • Current Issue
    • Issue Archives
  • Editor's Update
  • Advertise
  • Reprints
  • Authors
    • Author Instructions
    • Submission Portal
  • Reviewers
  • Contact

Search

Successful Prophylactic Use of an Inferior Vena Cava Filter Prevented a Fatal Pulmonary Embolism

  • Fri, 9/5/08 - 3:36pm
  • 0 Comments
  • 3760 reads
Author(s): 

1David Nicholson, DO and 2Charles Botti, MD

Background
Nearly 200,000 cases of deep venous thrombosis (DVT) occur each year.1 Dislodgement of a DVT with embolization to the pulmonary circulation results in a pulmonary embolism. One registry of 2454 patients diagnosed with a pulmonary embolism showed a three-month mortality rate of 17.5%.2 Perioperative prophylactic low-molecular weight heparin, fondaparinux, vitamin K antagonists, or sequential pneumatic compression stockings have been recommended to reduce risk of DVTs. For two decades, permanent inferior vena cava filters (IVCF) have served as an alternative in preventing pulmonary embolism (PE) when anticoagulation was contraindicated.3–5 This case graphically demonstrates the efficacy of a retrievable IVCF placed in a patient with a history of a DVT who was to undergo a total knee replacement.

Case report
A 55-year-old Caucasian male with no past medical history originally underwent arthroscopy for a meniscal tear in 2002. Postoperatively, he was diagnosed with a pulmonary emboli originating from a DVT. The patient then received six months of oral anticoagulation.

Two years later when a total knee replacement was required, a Günther Tulip Vena Cava Filter (GTF) (Cook Incorporated, Bloomington, Indiana) was inserted prior to surgery.

Following an uneventful total knee replacement, DVT prophylaxis with 30 mg enoxaparin injections was administered twice daily. The patient was taken to the endovascular lab several weeks later for retrieval of the GTF. An IVC gram surprisingly demonstrated a large filling defect within and around the GTF, representing a trapped embolus (Figure 1a). Thrombolysis was considered but was not initiated, due to the recent orthopedic procedure. The IVCF was left in place and full dose anticoagulation was begun. Four weeks later, the patient was brought to the endovascular lab for reevaluation of the trapped clot and possible thrombolysis. Digital subtraction angiography demonstrated marked improvement of the filter embolus (Figure 1b). The retrievable GTF was permanently left in the IVC, and the patient was to remain on lifetime anticoagulation.

Discussion
Over the past two decades IVCFs have prevented life threatening PE.6 Despite success in lowering PE mortality, complications from permanent IVCFs, which are undesirable for patients only transiently at high risk for thromboemboli, have been reported.7 Retrievable IVCFs, like the GTF, provide short-term protection while avoiding long-term morbidity.

Although technical experience with the GTF has grown, questions still remain as to the appropriate indications for use of the device. Few studies have examined the role of retrievable caval filter in preventing PE in high-risk surgical procedures. Rosner and associates evaluated the safety and efficacy of prophylactic IVCF placement in 22 high-risk patients who underwent major spine reconstruction. These authors concluded IVCF placement substantially decreased PE rates from 12% to 0%.8 Ferrell et al identified 6 patients, from a bariatric surgical registry of 586 patients, who were at high risk for thromboembolic complications and had an IVCF placed preoperatively.9 They concluded IVCF placement was feasible and safe for the morbidly obese individual undergoing gastric bypass, and should be considered for patients with risk factors for thromboembolic complications. Pieri et al placed 18 retrievable IVCF in patients who were to undergo invasive orthopedic surgery. Four of the 18 filters were prophylactically placed in patients at high risk for thromboembolic disease. These authors suggested that a retrievable IVCF was an ideal device to prevent pulmonary embolism in many clinical scenarios.10

In this case, we placed a retrievable IVCF for perioperative PE prophylaxis in a patient with a history of, but not current DVT, who was to undergo a high risk orthopedic procedure. If this patient did not have a prophylactic barrier present, a large, potentially fatal PE would have occurred. This case demonstrates graphically how a prophylactic retrievable IVCF can be life saving in a patient at risk for thromboembolic disease who is to undergo a procedure with known risk of DVT formation.

Conclusions
We recommend that during preoperative evaluation, prophylactic retrievable IVCF be considered for patients with known risk of forming thrombi, or for those undergoing procedures complicated by DVT formation, especially if anticoagulation is contraindicated.

References: 

1. Cushman M, Tsai AW, White RH, et al. Deep vein thrombosis and pulmonary embolism in two cohorts: The longitudinal investigation of thromboembolism etiology. Am J Med 2004;117:19–25.
2. Goldhaber SZ, DeRosa M, Visani L. International Cooperative Pulmonary Embolism registry detects high mortality rate. Circulation 1997;96:Suppl I:I–159.
3. Deitelzweig SB, Vanscoy GJ, Niccolai CS, Rihn TL. Venous thromboembolism prevention with LMWHs in medical and orthopedic surgery patients. Ann Pharmacother 2003;37:402–411.
4. Pitto RP, Hamer H, Heiss-Dunlop W, Kuehle J. Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br 2004;86:639–642.
5. Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation 2004;110:4–12.
6. Athanasoulis CA, Kaufman JA, Halpern EF, et al. Inferior vena caval filters: Review of a 26-year single-center clinical experience. Radiology 2000;216:54–66.
7. Ferris EJ, McCowan TC, Carver DK, McFarland DR. Percutaneous inferior vena caval filters: Follow-up of seven designs in 320 patients. Radiology 1993;188:851–856.
8. Rosner MK, KukloTR, Twak R, et al. Prophylactic placement of an inferior vena cava filter in high-risk patients undergoing spinal reconstruction. Neurosurg Focus 2004;17:1–6.
9. Ferrell A, Byrne TK, Robison JG. Placement of inferior vena cava filters in bariatric surgical patients — possible indications and technical considerations. Obes Surg 2004;14:738–743.
10. Pieri S, Agresti P, Morucci M, de' Medici L. Optional vena cava filters: Preliminary experience with a new vena cava filter. Radiol Med (Torino) 2003;105:56–62.

image description image description

Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Alex Dulnikowski, Classified Sales Manager
    (800) 237-7285, ext. 205

vdm Blogs

PROTECT carotid stent trial provides further evidence that CAS is getting better and becoming more competitive with CEA

Frank J Criado MD FACS FSVM

A New Algorithm to Treat Patients with Peripheral Vascular Disease

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT

In-Stent Restenosis in the SFA Remains a Significant Unresolved Problem

Frank J Criado MD FACS FSVM

Support Comes From Many Directions

Richard R. Heuser MD FACC FACP FESC FSCAI

Pedal Artery Access: Advances in Management of Critical limb ischemia

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study
    Thu, 02/09/12 - 10:52am
  • AngioDynamics Launches DuraFlow 2 Chronic Hemodialysis Catheter
    Wed, 02/08/12 - 10:18am
  • Robotic-Assisted Pci Procedures Using Corpath 200 System Will Be Discussed During CRT2012 Conference
    Tue, 02/07/12 - 10:00am
  • Vascular Solutions Launches Reprocessing Service For Closurefast Vein Catheters
    Fri, 02/03/12 - 1:14pm
more »

Clinical Events Calendar

  • American Venous Forum 24th Annual Meeting
    Wed, 02/08/2012 - Sat, 02/11/2012
    Orlando, FL, United States
  • JIM 2012
    Thu, 02/09/2012 - Sat, 02/11/2012
    Rome, Italy
  • Cardiovascular Care Update 2012 (CVC)
    Fri, 02/10/2012 - Sat, 02/11/2012
    Scottsdale, AZ, United States
more »

Poll

How do you feel about the continued practice of screening patients for asymptomatic CAD?:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2012 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2012 HMP Communications